Groundbreaking Malaria Vaccine under Test
Why in news?
- The World Health Organisation welcomed a pilot project in Malawi of administering a malaria vaccine to children below the age of 2 years. A total 3,60,000 children across three African countries — Malawi, Ghana and Kenya — will be covered every year with the vaccine.
What is the RTS, S (Mosquirix) vaccine?
- RTS, S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine.
- A pilot project for vaccination has been launched on April 23, 2019 in Malawi. Ghana and Kenya are to join the program later this year.
- The vaccine has been developed by GSK (GlaxoSmithKline ) ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Reimagining India’s Strategic Outlook: From Geography to Geometry of Interests
- 2 India’s Urban Future: Towards Inclusive and Resilient Cities
- 3 AI and Cyber Threats in India: Emerging Challenges to Digital Security
- 4 India’s Female Labour Force Participation: From Workforce Exclusion to Women-Led Growth
- 5 Food Safety Regulation in India: Strengthening Consumer Protection and Public Health
- 6 Floating Solar Parks: Powering India’s Renewable Transition
- 7 India’s Arctic Ambitions: From Observer to Active Player
- 8 India and Central Asia: Strengthening India’s Extended Neighbourhood
- 9 Urban Water Security: The Imperative for Water-Wise Cities
- 10 Strengthening Food Security and Nutrition for an Inclusive India
